The global Enzyme-Linked Immunosorbent Assay (ELISA) market is projected to grow at a CAGR of XX%, increasing from US$ XX billion in 2017 to US$ XX billion in 2023. ELISA (enzyme-linked immunosorbent assay) or enzyme immunoassay (EIA) is a plate-based assay technique designed for detecting and quantifying substances such as peptides, proteins, antibodies and hormones. ELISA is often used as a screening tool before more in-depth tests are ordered. Reactant of the ELISA are immobilized to the microplate surface making it easy to separate bound from non-bound material during the assay making it a powerful tool for measuring specific analytes within a crude preparation. The common diagnostic applications of ELISA are HIV infection, pregnancy tests, detection of proteins etc. The ELISA market is expected to show robust growth during the forecast period. The growth may be attributed to the rising incidence of infectious and chronic diseases which require ELISA as cost-effective diagnostic tools. However, stringent regulatory requirements as well as unfavourable reimbursement policies pertaining to ELISA might hamper the growth of the market during the given time frame.
This research study examines the current market trends related to the demand, supply, and sales, in addition to the recent developments. Major drivers, restraints, and opportunities have been covered to provide an exhaustive picture of the market. The analysis presents in-depth information regarding the development, trends, and industry policies and regulations implemented in each of the geographical region. Further, the overall regulatory framework of the market has been exhaustively covered to offer stakeholders a better understanding of the key factors affecting the overall market environment.
Identification of key industry players in the industry and their revenue contribution to the overall business or relevant segment aligned to the study have been covered as a part of competitive intelligence done through extensive secondary research. Various studies and data published by industry associations, analyst reports, investor presentations, press releases and journals among others have been taken into consideration while conducting the secondary research. Both bottom-up and top down approaches have been utilized to determine the market size of the overall market and key segments. The values obtained are correlated with the primary inputs of the key stakeholders in the global Enzyme-Linked Immunosorbent Assay (ELISA) market value chain. Last step involves complete market engineering which includes analysing the data from different sources and existing proprietary datasets while using various data triangulation methods for market breakdown and forecasting.
Market intelligence is presented in the form of analysis, charts, and graphics to help the clients in gaining faster and efficient understanding of the global Enzyme-Linked Immunosorbent Assay (ELISA) market.
Food and Beverage
By End Users
Hospitals and Clinics
Middle East and Africa
Key questions answered by the report
What will be the global Enzyme-Linked Immunosorbent Assay (ELISA) market size from 2018 to 2023?
How are the major drivers and restraints affecting the global Enzyme-Linked Immunosorbent Assay (ELISA) market growth and the opportunities which exist for key vendors?
Which segment and region will drive or lead the market growth and why?
A comprehensive analysis of competitive landscape and key market participants’ behaviour
Key strategies being adopted by vendors, with in-depth analysis along with their impact on competition and market growth